Leadership messaging now central to strategic execution

Tern plc

How leadership communicates is becoming a direct performance lever. Alignment at scale is only possible when communication creates shared meaning. Without that, even strong strategies risk weak execution.

Most companies track internal engagement through surveys, sentiment scores or attendance at events. These metrics offer reach but not clarity. They can show who heard the message, but not whether it was interpreted correctly. That disconnect matters. If staff take different meanings from leadership messages, they make different decisions, and execution drifts.

Message resonance is now a more useful metric. It asks a simple question: are people describing the same message in the same way? When language is consistent across teams, it shows the message has landed. When it isn’t, the gap becomes visible and fixable.

This approach shifts the focus from measuring inputs to tracking understanding. Companies are starting to use unstructured data, employee language in meetings, chat or feedback, to assess how leadership communication is being received and repeated. Analysing these patterns shows where messages are gaining traction, where they’re unclear, and where silence signals disengagement.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Peptide drug development expands beyond GLP-1

GLP-1 success is widening interest in peptide drug development, with the next phase focused on proving clinical value across new therapeutic areas.

Tern Plc announces 90% take-up of Open Offer

Tern Plc has received valid acceptances for 50.9 million Open Offer Shares, representing approximately 90% of the shares available. The fully underwritten offer will raise approximately £509,368 before expenses, with admission of the new shares expected on 24 September 2026.

Talking Medicines moves to capture pharma demand for better patient intelligence

Tighter US pharma advertising rules could increase demand for patient intelligence, supporting the relevance of Talking Medicines’ DrugVoice platform.

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent.

Device Authority targets secure digital infrastructure for smart ports

Device Authority's Smart, Green Port Blueprint shows how secure device management can support the wider rollout of connected infrastructure across modern ports.

Talking Medicines highlights strategic signals emerging across the GLP-1 consumer market

GLP-1 consumers are increasingly weighing access, affordability, quality, clinical oversight and treatment support, creating new strategic considerations across the wider life sciences market.

Search